Screening for a sometimes fatal condition among patients with a rare autoimmune disease could soon—thanks to a computer algorithm—become even more accurate.
Apr 21, 2021
0
10
For patients receiving background therapy for pulmonary arterial hypertension, treatment with sotatercept results in a reduction in pulmonary vascular resistance, according to a study published in the April 1 issue of the ...
Apr 1, 2021
0
5
Pulmonary arterial hypertension (PAH) is a rare—albeit deadly—disease that affects the arteries of the lung. In PAH, abnormal growth of cells of the vascular media—or the elastic wall—of the pulmonary arteries, called ...
Aug 7, 2020
0
4
A study recently published in the journal Circulation looks at temporal trends in the burden of comorbidities and associated risk of mortality among patients with heart failure (HF) with preserved ejection fraction (HFpEF), ...
Jul 30, 2020
0
4
Pulmonary arterial hypertension (PAH) is an insidious disease. Symptoms may begin slowly, and even before they appear, extensive damage has caused the obstruction of small arteries leading to increased blood pressure in the ...
Jul 21, 2020
0
67
Like many autoimmune diseases, systemic sclerosis, or scleroderma, can be a challenge to diagnose because its symptoms are varied, can range from mild to debilitating, and often resemble those of other conditions, such as ...
Jul 16, 2020
0
1
Pulmonary hypertension (PH) is a serious problem associated with a wide variety of lung diseases, which can lead to right ventricular dysfunction and death. Currently, there is no drug therapy to cure PH and the condition ...
Jun 15, 2020
0
1
In pulmonary arterial hypertension (PAH), high blood pressure in the lungs' arteries causes the heart to work extra hard to pump blood to the lungs and around the rest of the body. The condition is rare but deadly, and current ...
Feb 14, 2020
0
39
High blood pressure in the lungs, known as pulmonary arterial hypertension (PAH), is a potentially fatal disease caused by obstruction of blood flow in the lungs. A new study in The American Journal of Pathology sheds light ...
Dec 12, 2019
0
3
Scientists at the University of Sheffield, working in collaboration with drug and vaccine developer Kymab Ltd, Cambridge, have identified a novel antibody that has the potential to become a new treatment for pulmonary arterial ...
Nov 15, 2019
0
11
